This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre Hospitalier Régional Universitaire De Lille, Inserm (Institute National De La Santa Et De La Recherche Medicale), Instiut Pasteur De Lille. Active years: 2026.
Company Filing History:
1 out of 26 
1 out of 1 
1 out of 1 
Years Active: 2026
Title: Bart Staels: Innovator in Cardiovascular Research
Introduction
Bart Staels is a prominent inventor based in Lille, France. He has made significant contributions to the field of cardiovascular research, particularly in understanding and addressing aortic valve calcification. His innovative work has led to the development of a patent that holds promise for improving heart health.
Latest Patents
Bart Staels holds a patent titled "Use of retinoic acid receptor (RAR) agonists for reversing, preventing, or delaying calcification of aortic valve." This patent addresses aortic valve calcification, a condition characterized by calcium deposits forming on the aortic valve in the heart. These deposits can lead to a narrowing of the valve opening, known as aortic valve stenosis, which can severely reduce blood flow. His research demonstrates that retinoic acid can decrease calcification and the osteoblast-like phenotype in valvular interstitial cells (VICs). More specifically, RARα activation has been shown to reduce calcification and the osteoblast-like phenotype in VICs, while ALDH1A1 inhibition increases these conditions. This groundbreaking work suggests that RAR agonists could be effective in reversing, preventing, or delaying aortic valve calcification.
Career Highlights
Throughout his career, Bart Staels has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Lille. His research has significantly advanced the understanding of cardiovascular diseases and potential therapeutic approaches.
Collaborations
Bart Staels has collaborated with notable colleagues, including Sophie Susen and Delphine Corseaux. These partnerships have enriched his research and contributed to the development of innovative solutions in cardiovascular health.
Conclusion
Bart Staels is a key figure in cardiovascular research, with a patent that offers new insights into treating aortic valve calcification. His work exemplifies the importance of innovation in addressing critical health issues.